Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
US10137210B2 · kind B2 · utility
0Cited by
25References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 5, 2017 |
| Grant date | Nov 27, 2018 |
| Priority date | — |
| Expiry date | Oct 5, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/387
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to novel thioflavin derivatives, methods of using the derivatives in, for example, in vivo imaging of patients having neuritic plaques, pharmaceutical compositions comprising the thioflavin derivatives and method of synthesizing the compounds. The compounds find particular use in the diagnosis and treatment of patients having diseases where accumulation of neuritic plaques are prevalent. The disease states or maladies include but are not limited to Alzheimer's disease, familial Alzheimer's disease, Down's Syndrome and homozygotes for the apolipoprotein E4 allele.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.